Trials / Sponsors / Megan Kruse, MD
Megan Kruse, MD
Academic / Other · 1 registered clinical trial.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Suspended | Taletrectinib in Previously Treated Metastatic CDH1-mutated Invasive Lobular Cancer (ILC) Breast Cancer, Metastatic Breast Cancer | Phase 2 | 2026-04-01 |